| NEURONETICS INC. DL-,01 |
| USA |
| Gesundheit |
| US64131A1051 / A2JPMY |
| NRC (Frankfurt) / STIM (NASDAQ) |
| FRA:NRC, ETR:NRC, NRC:GR, NASDAQ:STIM |
| - |
| https://neurostar.com/ |
|
Neuronetics Inc. is a commercial stage medical technology and healthcare company focused on designing, developing, and marketing products that improve the quality of life for patients suffering from neurohealth and psychiatric disorders. Its primary ..
>Volltext.. |
| 89.42 Mio. EUR |
| 140.32 Mio. EUR |
| 129.22 Mio. EUR |
| -24.23 Mio. EUR |
| -33.78 Mio. EUR |
| -0.52 EUR |
| 78.23 Mio. EUR |
| 29.57 Mio. EUR |
| -17.65 Mio. EUR |
| 1.13 |
| 75.55% |
| 20.44% |
| - |
| - |
| - |
| NEURONETICS |
| 04.04.26 |